2022
DOI: 10.1016/j.euo.2022.07.004
|View full text |Cite
|
Sign up to set email alerts
|

Active Surveillance for Intermediate-risk Prostate Cancer: A Systematic Review, Meta-analysis, and Metaregression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

2
17
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 31 publications
(22 citation statements)
references
References 51 publications
2
17
0
Order By: Relevance
“…In a recent systematic review and meta-analysis, we showed that AS was associated with significantly higher risks of metastasis and cancer mortality in unselected patients with intermediate-risk PCa than in patients with low-risk PCa. 3 In subgroup analysis, we also showed in studies excluding GGG 3 intermediaterisk patients that treatment-free survival and metastasisfree survival were similar between low-and intermediaterisk patients. However, to date, the eligibility of intermediate-risk PCa patients for AS is limited by very strict consensus-based inclusion criteria, and these recommendations have been endorsed by the American Society of Clinical Oncology.…”
supporting
confidence: 57%
See 3 more Smart Citations
“…In a recent systematic review and meta-analysis, we showed that AS was associated with significantly higher risks of metastasis and cancer mortality in unselected patients with intermediate-risk PCa than in patients with low-risk PCa. 3 In subgroup analysis, we also showed in studies excluding GGG 3 intermediaterisk patients that treatment-free survival and metastasisfree survival were similar between low-and intermediaterisk patients. However, to date, the eligibility of intermediate-risk PCa patients for AS is limited by very strict consensus-based inclusion criteria, and these recommendations have been endorsed by the American Society of Clinical Oncology.…”
supporting
confidence: 57%
“…2 Our study had 15% of zero ischemia in the laparoscopic partial nephrectomy group vs 35% in the open partial nephrectomy group, with a median ischemia time of 14 minutes (7-25 minutes) for both groups, demonstrating the hypothesis that ischemia time has a shorter impact in long-term renal function. 3 We believe that image magnification of laparoscopy led the surgeon to perform a better enucleation of the tumor, preserving more healthy tissue.…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…In a recent systematic review and meta-analysis, we showed that AS was associated with significantly higher risks of metastasis and cancer mortality in unselected patients with intermediate-risk PCa than in patients with low-risk PCa. 3 In subgroup analysis, we also showed in studies excluding GGG 3 intermediate-risk patients that treatment-free survival and metastasis-free survival were similar between low- and intermediate-risk patients. However, to date, the eligibility of intermediate-risk PCa patients for AS is limited by very strict consensus-based inclusion criteria, and these recommendations have been endorsed by the American Society of Clinical Oncology.…”
supporting
confidence: 57%